XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
 [1]
Consolidated Statements of Operations and Comprehensive Income (Loss) [Abstract]    
Net sales $ 17,145 $ 20,941
Cost of sales 7,279 8,696
Gross profit 9,866 12,245
Operating expenses 11,096 10,032
Impairment expense 1,069 0
Income (loss) from operations (2,299) 2,213
Other (income) expense:    
Interest expense 0 32
Other, net (53) 110
Total other (income) expense (53) 142
Income (loss) before income taxes (2,246) 2,071
Provision (benefit) for income taxes (508) 551
Net income (loss) (1,738) [2] 1,520
Foreign currency translation adjustments, net of tax (346) 314
Comprehensive income (loss) $ (2,084) $ 1,834
Net income (loss) per common share:    
Basic (in dollars per share) $ (0.19) $ 0.17
Diluted (in dollars per share) $ (0.19) $ 0.17
Weighted average number of shares outstanding:    
Basic (in shares) 9,029,212 [2] 9,009,752
Diluted (in shares) 9,029,212 [2] 9,011,107
[1] As described in Note 2 to these Consolidated Financial Statements, we have restated the consolidated financial statements for the three months ended March 31, 2019
[2] For the three months ended March 31, 2020, there were 492 shares excluded from the diluted EPS calculation because the impact of their assumed vesting would be anti-dilutive due to a net loss in that period.